Societies

Hidehito Horinouchi summarizes some abstracts of WCLC24

Photo taken from Hidehito Horinouchi/X

Aug 16, 2024, 12:23

Hidehito Horinouchi summarizes some abstracts of WCLC24

Hidehito Horinouchi shared on X:

Antibody Drug Conjugates in SCLC by Charlie Rudin

Ifinatamab Deruxtecan (I-DXd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Ideate-lung01

Redefining First-Line EGFR Therapy by Anwen Xiong

Phase III Study of Rilertinib vs Gefitinib as 1st-Line Pts with Locally Advanced or Metastatic EGFR-m NSCLC

Perioperative Strategies 1 by Enriqueta Felip

IMpower010 5-y Subgroup Analysis and Relapse Patterns: Phase 3 Study of Atezolizumab vs BSC in Stage II-IIIA NSCLC

Perioperative Strategies 1 by Jones David R.

Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Periope Pembro for Early-Stage NSCLC

Presidential 2 by Xiuning Le

FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations

Presidential 2 by J. Yang

Osimertinib With or Without Savolitinib as 1L in De Novo MET Aberrant, EGFRm Advanced NSCLC (CTONG 2008): A Phase II Trial

Presidential 1 by Annette McWilliams

Triaging ILST Screening Participants at Program Entry: Comparative Performance of PanCan versus LungRADSv1.1

Presidential 1 by Marina Garassino

Normalized Membrane Ratio of TROP2 by Quantitative Continuous Scoring is predictive of Outcomes in TROPION-Lung 01

Find more abstract summaries by Hidehito Horinouchi on Hidehito Horinouchi/X

Hidehito Horinouchi is the Assistant Chief of the National Cancer Center Hospital. He also serves as the Secretary General of the Lung Cancer Study Group, Japan Clinical Oncology Group, and the Deputy Chief of the Center for Education and Professional Career Development at the National Cancer Center Hospital. He specializes in multimodal treatment strategies, including medical, surgical, and radiation oncology, for patients with thoracic malignancies.

Annette McWilliams Anwen Xiong cancer Charlie Rudin EGFR Enriqueta Felip Hidehito Horinouchi J. Yang Jones David R. Marina Garassino National Cancer Center Hospital NSCLC OncoDaily Oncology WCLC24 Xiuning Le

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage